Llorente/Sandvig publish potential biomarkers for prostate cancer
Alicia Llorente and Kirsten Sandvig, Department of Biochemistry, Institute for Cancer Research and Centre for Cancer Biomedicine, have recently published in Molecular and Cellular Proteomics (impact factor 8.4) a proteomic analysis of microvesicles released from a human prostate cancer cell line. Most of the 266 proteins identified have previously been reported to be present in vesicles released from other cell types, but several proteins seem to be specific for prostate cancer cells. Since microvesicles can reach biological fluids, these proteins are thus potentially useful as new non invasive biomarkers for detection, diagnosis and/or prognosis of prostate cancer.
From major journals, first or last author from the Institute for Cancer Research
Hektoen HH, Tsuruda KM, Fjellbirkeland L, Nilssen Y, Brustugun OT, Andreassen BK(2024) Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study Br J Cancer(in press) DOI 10.1038/s41416-024-02895-1, PubMed 39489879
Egeland EV, Seip K, Skourti E, Øy GF, Pettersen SJ, Pandya AD, Dahle MA, Haugen MH, Kristian A, Nakken S, Engebraaten O, Mælandsmo GM, Prasmickaite L(2024) The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy Br J Cancer(in press) DOI 10.1038/s41416-024-02875-5, PubMed 39390250
Møller P, Seppälä TT, Dominguez-Valentin M, Sampson J(2024) Commentary on Estimating cancer risk in carriers of Lynch syndrome variants in UK Biobank J Med Genet(in press) DOI 10.1136/jmg-2024-110385, PubMed 39375027
Hektoen HH, Tsuruda KM, Fjellbirkeland L, Nilssen Y, Brustugun OT, Andreassen BK(2024) Real-world evidence for pembrolizumab in non-small cell lung cancer: a nationwide cohort study Br J Cancer(in press) DOI 10.1038/s41416-024-02895-1, PubMed 39489879
Strunz B, Momayyezi P, Bilev E, Muvva JR, Chen P, Bister J, Schaffer M, Akber M, Cornillet M, Karolinska KI/K COVID-19 Study Group, Horowitz A, Malmberg KJ, Rooyackers O, Aleman S, Ljunggren HG, Björkström NK, Strålin K, Hammer Q(2024) The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19 Genes Immun(in press) DOI 10.1038/s41435-024-00302-6, PubMed 39487235
Palacios D, Majhi RK, Szabo EK, Clement D, Lachota M, Netskar H, Penna L, Krokeide SZ, Vincenti M, Kveberg L, Malmberg KJ(2024) The G Protein-Coupled Receptor GPR56 Is an Inhibitory Checkpoint for NK Cell Migration J Immunol, 213(9), 1349-1357 DOI 10.4049/jimmunol.2400228, PubMed 39320215